212 related articles for article (PubMed ID: 17713444)
1. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
[TBL] [Abstract][Full Text] [Related]
2. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
[TBL] [Abstract][Full Text] [Related]
4. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
5. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
6. Importance of donor- and recipient-derived selectins in cardiac allograft rejection.
Izawa A; Ueno T; Jurewicz M; Ito T; Tanaka K; Takahashi M; Ikeda U; Sobolev O; Fiorina P; Smith RN; Hynes RO; Abdi R
J Am Soc Nephrol; 2007 Nov; 18(11):2929-36. PubMed ID: 17928506
[TBL] [Abstract][Full Text] [Related]
7. Acute rejection of vascular heart allografts by perforin-deficient mice.
Schulz M; Schuurman HJ; Joergensen J; Steiner C; Meerloo T; Kägi D; Hengartner H; Zinkernagel RM; Schreier MH; Bürki K
Eur J Immunol; 1995 Feb; 25(2):474-80. PubMed ID: 7533086
[TBL] [Abstract][Full Text] [Related]
8. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
10. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.
Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY
Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
14. 3-Deazaadenosine prevents leukocyte invasion by suppression of adhesion molecule expression during acute cardiac allograft rejection: involvement of apoptotic cell death.
Fingerhuth H; Hölschermann H; Grimm H; Tillmanns H; Haberbosch W; Braun-Dullaeus RC; Stadlbauer TH
J Heart Lung Transplant; 2004 Aug; 23(8):970-8. PubMed ID: 15312827
[TBL] [Abstract][Full Text] [Related]
15. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
[TBL] [Abstract][Full Text] [Related]
16. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
17. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
Soleimani B; Fu F; Lake P; Shi VC
J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
[TBL] [Abstract][Full Text] [Related]
18. Endothelial activation and chronic allograft rejection.
Orosz CG
Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
[TBL] [Abstract][Full Text] [Related]
19. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
20. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]